SANDRA
MUNTION OLAVE
Forscherin seit 2018
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (9)
2022
-
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
Therapeutic Advances in Hematology, Vol. 13
-
Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia
Frontiers in Bioengineering and Biotechnology, Vol. 10
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo
Stem Cell Research and Therapy, Vol. 12, Núm. 1
-
Improving hematopoietic engraftment: Potential role of mesenchymal stromal cell-derived extracellular vesicles
Stem Cells, Vol. 39, Núm. 1, pp. 26-32
-
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
Stem Cell Research and Therapy, Vol. 12, Núm. 1
2019
-
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
Stem Cells, Vol. 37, Núm. 10, pp. 1357-1368
2018
-
Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 3, pp. 443-451